Inactive Instrument

News Eastgate Biotech Corp. Other OTC

Equities

ETBI

US2772531008

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

EastGate Biotech Corp. Enters Into a 3-way International Distribution Agreement With Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc.	21-05-17	GL
EastGate Biotech Corp., Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc. Enter Into a 3-way International Distribution Agreement	21-05-17	CI
EastGate Biotech Corp. Enters into a Licensing and Distribution Agreement for Glucora, One of Its Nutraceutical Products for the US, Canadian, Central and South American Markets	21-03-08	GL
EastGate Biotech Corp. Enters into A Licensing and Distribution Agreement for Glucora	21-03-08	CI
EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19	20-02-18	GL
EastGate Biotech Corp. and EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19	20-02-18	CI
Eastgate Biotech Corp. Announces Phase 3 Clinical Trials of Insurgin	20-02-05	CI
EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement	20-02-05	NE
EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus	20-01-30	GL
EastGate Biotech Corp. Partners with EastGate Biotech Pakistan for the International Marketing Rights of Anaferon	20-01-30	CI
EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights	19-12-30	GL
EastGate Biotech Expands Pipeline to Alzheimer’s Disease Using its Alternative Insulin Delivery Platform	19-11-14	GL
EastGate Biotech Corp Expands Pipeline to Alzheimer’S Disease Using Its Alternative Insulin Delivery Platform	19-11-14	CI
EastGate Biotech Announces Expansion and Restructuring of Joint Venture with its Partner in Pakistan	19-10-09	GL
Eastgate Biotech Corp. Announces Expansion and Restructuring of Joint Venture with Its Partner in Pakistan	19-10-09	CI
EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution	19-09-25	GL
EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution	19-09-25	CI
EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer	19-09-04	GL
Eastgate Biotech Corp. Appoints Bill Abajian as Chief Operating Officer	19-09-04	CI
EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin	19-06-26	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Eastgate Biotech Corp. Other OTC

Equities

ETBI

US2772531008

Summary

Filters